Status:
UNKNOWN
ObServatory Children Acute RElated Therapy Leukemia
Lead Sponsor:
University Hospital, Bordeaux
Conditions:
Leukemia, Myeloid, Acute
Eligibility:
All Genders
Up to 18 years
Brief Summary
Acute Myeloid Leukemias (AML) of the child are a rare disease and its prognosis varies according to the subgroup. Secondary AMLs remain a subgroup of poor prognosis, whose cytogenetic and molecular ch...
Detailed Description
Therapy-related myeloid neoplasms (t-MNs) are a group of hematologic diseases that arise after chemotherapy and/or radiation therapy for a previous cancer or rarely autoimmune diseases. t-MNs had been...
Eligibility Criteria
Inclusion
- Patients aged 0-18 years
- Patient with first cancer
- Diagnosis of secondary AML
- Patients treated in a SFCE (Société française des cancers de l'enfant) center
- For cases included in the prospective from March 2019 onwards: Consent of holders of parental authority and consent of the child of understanding age
Exclusion
- None
Key Trial Info
Start Date :
September 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2024
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04450784
Start Date
September 1 2020
End Date
September 1 2024
Last Update
July 1 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.